Daily oral PrEP is effective in reducing HIV transmission, yet uptake among men who have sex with men (MSM) has been slow in the United States. In this study, we sought to identify strategies that would yield the highest reduction in HIV incidence among MSM to help guide a statewide implementation effort and achieve the National HIV/AIDS Strategy goal of reducing new diagnoses by 25% over 10 years.
We used a discrete-time, stochastic agent-based model representing all MSM aged 15–74 in Rhode Island ([i]N[/i] = 25,000), a state with approximately 4–5% HIV prevalence among MSM. We simulated the following scenarios in which different populations of MSM were engaged for PrEP uptake: 1) [i]Current Patient Population[/i] – selection based on distributions of age and partner degree among actual patients in a PrEP program implemented according to CDC guidelines; 2) [i]Random[/i] – random allocation, all HIV-negative MSM eligible; 3) [i]Partner Number (PN)[/i] – Annual partner number greater than 5 or 10. The model was calibrated to reproduce statewide prevalence from 2009 through 2014. For each simulation, PrEP was implemented after this 6-year lead-in period and maintained at a fixed coverage level for the next 10 years. Scenarios were simulated 1,000 times each, with 5–30% PrEP coverage of the HIV-negative population.
From 2015–2025, a median of 826 new HIV infections were predicted across the entire population in the absence of PrEP. At 15% PrEP coverage of HIV-negative MSM, 3 of the 4 scenarios achieved a greater than 25% reduction in cumulative incidence, exceeding the National HIV/AIDS Strategy goal in this timeframe (Table). A 25% reduction in the median cumulative incidence, relative to the scenario without PrEP, was apparent after 9.1, 6.8, and 3.4 years in the Current Patient Population, PN > 5, and PN > 10 scenarios, respectively. The only scenario to approach the goal at lower PrEP coverage was the PN > 10 scenario, which achieved a 23.5% (95% simulation interval: 10.9, 34.3) reduction in new infections at 10% population coverage over 10 years.
Under most of the scenarios tested, PrEP coverage of 15% was sufficient to reduce cumulative incidence by 25% over 10 years. Focused implementation efforts on MSM who have larger numbers of partners may maximize PrEP’s impact and possibly its cost-effectiveness at lower levels of population coverage.